Wael Yassin Mansour

10PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nonlinear optics and spectroscopy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 07, 2026
Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

|Mar 09, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.

Fabrizio Di Costanzo, Jack Williamson, Craig N Robson

|Apr 29, 2025
6-[(1,4-Naphthoquinone-2-yl)methyl]thio-Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer.

Tobias Busenbender, Dmitry N Pelageev, Jessica Hauschild

|Jan 25, 2023
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.

Mohamed E Elsesy, Su Jung Oh-Hohenhorst, Christoph Oing

|Dec 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer.

Gunhild von Amsberg, Mirjam Zilles, Wael Mansour

|Aug 07, 2021
Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer.

Maha Elazezy, Sandra Schwentesius, Luisa Stegat

Pageof 2

Frequent Collaborators

3 joint publications

Sergey Dyshlovoy

3 joint publications

Christoph Oing

2 joint publications

Lukas Boeckelmann

2 joint publications

Derya Tilki